Das Anthony Vipin, Senthil Sirisha
Department of EyeSmart EMR & AEye, L V Prasad Eye Institute, Hyderabad, India.
Indian Health Outcomes, Public Health and Economics Research Center, L V Prasad Eye Institute, Hyderabad, India.
Front Ophthalmol (Lausanne). 2022 Jul 6;2:900988. doi: 10.3389/fopht.2022.900988. eCollection 2022.
To describe the demographics and clinical profile of patients with glaucoma presenting during the novel coronavirus (COVID-19) lockdown and unlock phases in India.
This retrospective hospital-based comparative study included patients presenting between March 25, 2017, and March 31, 2021. All patients who presented with glaucoma disorders were included as cases. The demographic and clinical data of these glaucoma patients were collected using an electronic medical record system.
Overall, 34,419 patients (mean 47 per day) diagnosed with glaucoma diseases presented to the network and were included for analysis. The mean age of the patients was 54.16 ± 18.74 years and most were male (n=21,140; 61.42%) from the urban region (n=12,871;37.4%). On categorizing based on the timeline of the COVID-19 pandemic, most of the patients presented pre-COVID-19 (n=29,122; 84.61%), followed by a minority (n=175; 0.51%) during the lockdown and the rest (n=5,122; 14.88%) during unlock phase. An increasing number of patients with secondary glaucoma (n=82; 46.86%) and presenting from the local intra-city (n=82; 46.86%) was seen during the lockdown. There was a 6.6-fold increase in neovascular glaucoma and a 2.7-fold increase in lens induced glaucoma during the lockdown phase ((p<0.001) for both). There was a significant increase in subjects in 4 decade (p<0.03) and a decrease in subjects in 7 decade (p<0.008) during the lockdown period.
The presentation of patients with glaucoma disorders to the hospital is evolving due to the COVID-19 pandemic. The footfalls of patients during the unlock regained to two-thirds of the pre COVID-19 level. During the lockdown, the older patients were less, there was an increase in younger patients and those with secondary glaucoma, and the majority presenting from within the city.
描述在印度新型冠状病毒（COVID-19）封锁和解封阶段就诊的青光眼患者的人口统计学特征和临床概况。
这项基于医院的回顾性比较研究纳入了2017年3月25日至2021年3月31日期间就诊的患者。所有诊断为青光眼疾病的患者均作为病例纳入。这些青光眼患者的人口统计学和临床数据通过电子病历系统收集。
总体而言，34419例（平均每天47例）诊断为青光眼疾病的患者前来该医疗网络就诊并被纳入分析。患者的平均年龄为54.16±18.74岁，大多数为男性（n=21140；61.42%），来自城市地区（n=12871；37.4%）。根据COVID-19大流行的时间线进行分类，大多数患者在COVID-19之前就诊（n=29122；84.61%），其次是在封锁期间少数患者（n=175；0.51%），其余患者（n=5122；14.88%）在解封阶段就诊。在封锁期间，继发性青光眼患者数量增加（n=82；46.86%），且来自市内当地的患者数量增加（n=82；46.86%）。在封锁阶段，新生血管性青光眼增加了6.6倍，晶状体诱导性青光眼增加了2.7倍（两者p<0.001）。在封锁期间，40多岁的患者数量显著增加（p<0.03），70多岁的患者数量减少（p<0.008）。
由于COVID-19大流行，青光眼疾病患者到医院就诊的情况正在发生变化。解封期间患者的就诊量恢复到COVID-19之前水平的三分之二。在封锁期间，老年患者较少，年轻患者和继发性青光眼患者有所增加，且大多数患者来自市内。
